EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dapagliflozin Attenuates Myocardial Inflammation and Apoptosis after Coronary Microembolization in Rats by Regulating the SIRT1/NF-κB Signaling Pathway

Tao Li, Chang-Jun Luo, Ze-Qiang Yi, Lang Li

Frontiers in Bioscience-Landmark · 2025

DOI: 10.31083/fbl27082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Tao Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, 530021 Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Glucosides, Sirtuin 1, Apoptosis, NF-kappa B. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Coronary microembolization (CME) often occurs as a serious complication during or after percutaneous coronary intervention (PCI), leading to an impairment in heart function, inflammation, and cell death. Dapagliflozin (DAPA) has been shown to have cardioprotective effects. However, its role and exact mechanism in CME remains unclear.

Methods

A preclinical CME model was developed via the administration of microspheres into the left ventricle. In an in vitro model, the CME-created microenvironment was observed by using lipopolysaccharide (LPS) with hypoxic induction on H9C2 cardiomyocytes. Before developing both experimental models, DAPA or the sirtuin 1 (SIRT1) inhibitor “EX-527” was administered. Echocardiography, histological examination, and molecular and immunological assays were carried out to assess the levels of cardiac tissue or cardiomyocyte damage, inflammation, and apoptosis.

Results

Heart dysfunction and tissue damage caused by CME can be alleviated by pre-treatment with DAPA, which also reduces myocardial inflammation and apoptosis. Moreover, both experimental studies have depicted that DAPA can upregulate the SIRT1 level and downregulate the acetylation and phosphorylation levels of nuclear factor kappa-B (NF-κB) p65. This effect inhibits the induction of NF-κB signaling and mitigates cardiomyocyte damage. However, DAPA’s cardioprotective effect was reversed when co-treated with EX-527.

Conclusions

DAPA reduces myocardial damage caused by CME by suppressing myocarditis and apoptosis via the SIRT1/NF-κB axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucosidesSirtuin 1ApoptosisNF-kappa BBenzhydryl CompoundsMyocarditisAnimalsSignal TransductionRatsMaleMyocytes, CardiacRats, Sprague-DawleyCell LineMyocardiumInflammationDisease Models, AnimalCarbazoles

Stichwörter der Autor:innen

SIRT1apoptosiscoronary microembolizationdapagliflozininflammation

Substanzen

GlucosidesSirtuin 1dapagliflozinNF-kappa BSirt1 protein, ratBenzhydryl Compounds6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamideCarbazoles

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, 530021 Nanning, Guangxi, China.
  • Department of Cardiology, Affiliated Liutie Central Hospital of Guangxi Medical University, 545007 Liuzhou, Guangxi, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, T., Luo, C. J., Yi, Z. Q., & Li, L. (2025). Dapagliflozin Attenuates Myocardial Inflammation and Apoptosis after Coronary Microembolization in Rats by Regulating the SIRT1/NF-κB Signaling Pathway. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl27082

Vancouver

Li T, Luo CJ, Yi ZQ, Li L. Dapagliflozin Attenuates Myocardial Inflammation and Apoptosis after Coronary Microembolization in Rats by Regulating the SIRT1/NF-κB Signaling Pathway. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl27082

BibTeX
@article{Li2025,
  author = {Li, Tao and Luo, Chang-Jun and Yi, Ze-Qiang and Li, Lang},
  title = {Dapagliflozin Attenuates Myocardial Inflammation and Apoptosis after Coronary Microembolization in Rats by Regulating the SIRT1/NF-κB Signaling Pathway},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  doi = {10.31083/fbl27082}
}
Kostenlos starten →